{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T07:05:17Z","timestamp":1790751917222,"version":"4.1.0"},"reference-count":94,"publisher":"Spandidos Publications","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Ther Med"],"DOI":"10.3892\/etm.2023.11974","type":"journal-article","created":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T11:49:34Z","timestamp":1682077774000},"source":"Crossref","is-referenced-by-count":11,"title":["New insights on IL\u201136 in intestinal inflammation and colorectal cancer (Review)"],"prefix":"10.3892","volume":"25","author":[{"given":"Minghui","family":"Li","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu 210006, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu 210006, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zehui","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu 210006, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihan","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu 210006, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu 210006, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2023,4,21]]},"reference":[{"key":"key20230526101648_b1-ETM-25-6-11974","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1006\/geno.2002.6752","article-title":"Genomic organization of the interleukin-1 locus","volume":"79","author":"Taylor","year":"2002","journal-title":"Genomics"},{"key":"key20230526101648_b2-ETM-25-6-11974","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1074\/jbc.275.2.1169","article-title":"Four new members expand the interleukin-1 superfamily","volume":"275","author":"Smith","year":"2000","journal-title":"J Biol Chem"},{"key":"key20230526101648_b3-ETM-25-6-11974","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/s1471-4906(01)02034-8","article-title":"Annotating genes with potential roles in the immune system: Six new members of the IL-1 family","volume":"22","author":"Dunn","year":"2001","journal-title":"Trends Immunol"},{"issue":"973","key":"key20230526101648_b4-ETM-25-6-11974","doi-asserted-by":"publisher","DOI":"10.1038\/ni1110-973","article-title":"IL-1 family nomenclature","volume":"11","author":"Dinarello","year":"2010","journal-title":"Nat Immunol"},{"key":"key20230526101648_b5-ETM-25-6-11974","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/s1471-4906(01)02040-3","article-title":"A new nomenclature for IL-1-family genes","volume":"22","author":"Sims","year":"2001","journal-title":"Trends Immunol"},{"key":"key20230526101648_b6-ETM-25-6-11974","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.celrep.2015.12.072","article-title":"Neutrophil-derived proteases escalate inflammation through activation of IL-36 family cytokines","volume":"14","author":"Henry","year":"2016","journal-title":"Cell Rep"},{"issue":"24880","key":"key20230526101648_b7-ETM-25-6-11974","doi-asserted-by":"publisher","DOI":"10.1038\/srep24880","article-title":"Neutrophil elastase-mediated proteolysis activates the anti-inflammatory cytokine IL-36 receptor antagonist","volume":"6","author":"Macleod","year":"2016","journal-title":"Sci Rep"},{"key":"key20230526101648_b8-ETM-25-6-11974","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1111\/imr.12610","article-title":"Regulation and function of interleukin-36 cytokines","volume":"281","author":"Bassoy","year":"2018","journal-title":"Immunol Rev"},{"key":"key20230526101648_b9-ETM-25-6-11974","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1189\/jlb.3RI1014-495R","article-title":"Regulation and function of interleukin-36 cytokines in homeostasis and pathological conditions","volume":"97","author":"Gabay","year":"2015","journal-title":"J Leukocyte Biol"},{"key":"key20230526101648_b10-ETM-25-6-11974","doi-asserted-by":"publisher","first-page":"13677","DOI":"10.1074\/jbc.M400117200","article-title":"Interleukin (IL)-1F6, IL-1F8, and IL-1F9 signal through IL-1Rrp2 and IL-1RAcP to activate the pathway leading to NF-kappaB and MAPKs","volume":"279","author":"Towne","year":"2004","journal-title":"J Biol Chem"},{"key":"key20230526101648_b11-ETM-25-6-11974","doi-asserted-by":"publisher","first-page":"42594","DOI":"10.1074\/jbc.M111.267922","article-title":"Interleukin-36 (IL-36) ligands require processing for full agonist (IL-36\u03b1, IL-36\u03b2, and IL-36\u03b3) or antagonist (IL-36Ra) activity","volume":"286","author":"Towne","year":"2011","journal-title":"J Biol Chem"},{"issue":"786","key":"key20230526101648_b12-ETM-25-6-11974","doi-asserted-by":"publisher","DOI":"10.1038\/d41573-022-00172-5","article-title":"FDA approves first anti-IL-36 receptor antibody for rare skin disease","volume":"21","author":"Mullard","year":"2022","journal-title":"Nat Rev Drug Discov"},{"key":"key20230526101648_b13-ETM-25-6-11974","doi-asserted-by":"publisher","first-page":"2895","DOI":"10.18632\/oncotarget.22814","article-title":"IL-36 cytokines in autoimmunity and inflammatory disease","volume":"9","author":"Ding","year":"2017","journal-title":"Oncotarget"},{"key":"key20230526101648_b14-ETM-25-6-11974","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1111\/cei.12761","article-title":"Distinct expression of interleukin (IL)-36\u03b1, \u03b2 and \u03b3, their antagonist IL-36Ra and IL-38 in psoriasis, rheumatoid arthritis and Crohn's disease","volume":"184","author":"Boutet","year":"2016","journal-title":"Clin Exp Immunol"},{"key":"key20230526101648_b15-ETM-25-6-11974","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1053\/j.gastro.2018.11.029","article-title":"Inhibiting interleukin 36 receptor signaling reduces fibrosis in mice with chronic intestinal inflammation","volume":"156","author":"Scheibe","year":"2019","journal-title":"Gastroenterology"},{"key":"key20230526101648_b16-ETM-25-6-11974","doi-asserted-by":"publisher","first-page":"E5076","DOI":"10.1073\/pnas.1718902115","article-title":"A cytokine network involving IL-36\u03b3, IL-23, and IL-22 promotes antimicrobial defense and recovery from intestinal barrier damage","volume":"115","author":"Ngo","year":"2018","journal-title":"Proc Natl Acad Sci USA"},{"issue":"317","key":"key20230526101648_b17-ETM-25-6-11974","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2019.00317","article-title":"Function and regulation of IL-36 signaling in inflammatory diseases and cancer development","volume":"7","author":"Queen","year":"2019","journal-title":"Front Cell Dev Biol"},{"key":"key20230526101648_b18-ETM-25-6-11974","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1042\/BST20211264","article-title":"The role of IL-36 subfamily in intestinal disease","volume":"50","author":"Xu","year":"2022","journal-title":"Biochem Soc Trans"},{"issue":"92","key":"key20230526101648_b19-ETM-25-6-11974","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-020-6587-z","article-title":"IL-36 s in the colorectal cancer: Is interleukin 36 good or bad for the development of colorectal cancer?","volume":"20","author":"Chen","year":"2020","journal-title":"Bmc Cancer"},{"key":"key20230526101648_b20-ETM-25-6-11974","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1007\/s12551-020-00726-0","article-title":"IL-34, IL-36 and IL-38 in colorectal cancer-key immunoregulators of carcinogenesis","volume":"12","author":"Bao","year":"2020","journal-title":"Biophys Rev"},{"key":"key20230526101648_b21-ETM-25-6-11974","doi-asserted-by":"publisher","first-page":"6215","DOI":"10.1007\/s00018-021-03909-4","article-title":"IL-36 cytokines in inflammatory and malignant diseases: Not the new kid on the block anymore","volume":"78","author":"Byrne","year":"2021","journal-title":"Cell Mol Life Sci"},{"key":"key20230526101648_b22-ETM-25-6-11974","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/5584_2020_488","article-title":"Interleukin-36: Structure, signaling and function","volume":"21","author":"Zhou","year":"2021","journal-title":"Adv Exp Med Biol"},{"key":"key20230526101648_b23-ETM-25-6-11974","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s00441-021-03495-8","article-title":"Compartmentalization of interleukin 36 subfamily according to inducible and constitutive expression in the kidneys of a murine autoimmune nephritis model","volume":"386","author":"Namba","year":"2021","journal-title":"Cell Tissue Res"},{"issue":"1162","key":"key20230526101648_b24-ETM-25-6-11974","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01162","article-title":"Interleukin-36 in infectious and inflammatory skin diseases","volume":"10","author":"Buhl","year":"2019","journal-title":"Front Immunol"},{"key":"key20230526101648_b25-ETM-25-6-11974","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.intimp.2018.03.011","article-title":"Increased serum IL-36\u03b1 and IL-36\u03b3 levels in patients with systemic lupus erythematosus: Association with disease activity and arthritis","volume":"58","author":"Mai","year":"2018","journal-title":"Int Immunopharmacol"},{"issue":"727956","key":"key20230526101648_b26-ETM-25-6-11974","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.727956","article-title":"The role of IL-36 in the pathophysiological processes of autoimmune diseases","volume":"12","author":"Chen","year":"2021","journal-title":"Front Pharmacol"},{"key":"key20230526101648_b27-ETM-25-6-11974","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1038\/s41584-019-0277-8","article-title":"The IL-1 family of cytokines and receptors in rheumatic diseases","volume":"15","author":"Dinarello","year":"2019","journal-title":"Nat Rev Rheumatol"},{"key":"key20230526101648_b28-ETM-25-6-11974","doi-asserted-by":"publisher","first-page":"5813","DOI":"10.1182\/blood-2011-05-356873","article-title":"IL-36R ligands are potent regulators of dendritic and T cells","volume":"118","author":"Vigne","year":"2011","journal-title":"Blood"},{"key":"key20230526101648_b29-ETM-25-6-11974","doi-asserted-by":"publisher","first-page":"6053","DOI":"10.4049\/jimmunol.1301481","article-title":"IL-36 promotes myeloid cell infiltration, activation, and inflammatory activity in skin","volume":"192","author":"Foster","year":"2014","journal-title":"J Immunol"},{"key":"key20230526101648_b30-ETM-25-6-11974","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.1038\/jid.2011.234","article-title":"Inter-regulation of Th17 cytokines and the IL-36 cytokines in vitro and in vivo: implications in psoriasis pathogenesis","volume":"131","author":"Carrier","year":"2011","journal-title":"J Invest Dermatol"},{"key":"key20230526101648_b31-ETM-25-6-11974","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/j.jid.2019.08.444","article-title":"IL-36 promotes systemic IFN-I responses in severe forms of psoriasis","volume":"140","author":"Catapano","year":"2020","journal-title":"J Invest Dermatol"},{"key":"key20230526101648_b32-ETM-25-6-11974","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1038\/s41416-022-02083-z","article-title":"Transcriptomic and functional analyses reveal a tumour-promoting role for the IL-36 receptor in colon cancer and crosstalk between IL-36 signalling and the IL-17\/ IL-23 axis","volume":"128","author":"Baker","year":"2023","journal-title":"Brit J Cancer"},{"issue":"e1006737","key":"key20230526101648_b33-ETM-25-6-11974","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1006737","article-title":"Interleukin-36\u03b3 and IL-36 receptor signaling mediate impaired host immunity and lung injury in cytotoxic Pseudomonas aeruginosa pulmonary infection: Role of prostaglandin E2","volume":"13","author":"Aoyagi","year":"2017","journal-title":"PLoS Pathog"},{"key":"key20230526101648_b34-ETM-25-6-11974","doi-asserted-by":"publisher","first-page":"922","DOI":"10.4049\/jimmunol.1900169","article-title":"IL-36\u03b3 promotes killing of mycobacterium tuberculosis by macrophages via WNT5A-induced noncanonical WNT signaling","volume":"203","author":"Gao","year":"2019","journal-title":"J Immunol"},{"key":"key20230526101648_b35-ETM-25-6-11974","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1038\/mi.2016.130","article-title":"IL-36\u03b3 is a crucial proximal component of protective type-1-mediated lung mucosal immunity in Gram-positive and -negative bacterial pneumonia","volume":"10","author":"Kovach","year":"2017","journal-title":"Mucosal Immunol"},{"key":"key20230526101648_b36-ETM-25-6-11974","doi-asserted-by":"publisher","first-page":"16597","DOI":"10.1074\/jbc.M116.723064","article-title":"Structural and functional attributes of the interleukin-36 receptor","volume":"291","author":"Yi","year":"2016","journal-title":"J Biol Chem"},{"key":"key20230526101648_b37-ETM-25-6-11974","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1111\/imm.13462","article-title":"The roles of interleukin-1 receptor accessory protein in certain inflammatory conditions","volume":"166","author":"Zarezadeh Mehrabadi","year":"2022","journal-title":"Immunology"},{"key":"key20230526101648_b38-ETM-25-6-11974","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1074\/jbc.M117.805739","article-title":"Quantitative ligand and receptor binding studies reveal the mechanism of interleukin-36 (IL-36) pathway activation","volume":"293","author":"Zhou","year":"2018","journal-title":"J Biol Chem"},{"key":"key20230526101648_b39-ETM-25-6-11974","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1080\/19420862.2017.1353853","article-title":"Generation and functional characterization of anti-human and anti-mouse IL-36R antagonist monoclonal antibodies","volume":"9","author":"Ganesan","year":"2017","journal-title":"MAbs"},{"key":"key20230526101648_b40-ETM-25-6-11974","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.ajhg.2011.07.022","article-title":"Mutations in IL36RN\/IL1F5 are associated with the severe episodic inflammatory skin disease known as generalized pustular psoriasis","volume":"89","author":"Onoufriadis","year":"2011","journal-title":"Am J Hum Genet"},{"key":"key20230526101648_b41-ETM-25-6-11974","doi-asserted-by":"publisher","first-page":"3001","DOI":"10.1073\/pnas.1121534109","article-title":"IL-38 binds to the IL-36 receptor and has biological effects on immune cells similar to IL-36 receptor antagonist","volume":"109","author":"van de Veerdonk","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20230526101648_b42-ETM-25-6-11974","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.jtos.2021.08.012","article-title":"IL-36\u03b1\/IL-36RA\/IL-38 signaling mediates inflammation and barrier disruption in human corneal epithelial cells under hyperosmotic stress","volume":"22","author":"Li","year":"2021","journal-title":"Ocul Surf"},{"key":"key20230526101648_b43-ETM-25-6-11974","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/imm.13310","article-title":"IL-36 cytokines and gut immunity","volume":"163","author":"Ngo","year":"2021","journal-title":"Immunology"},{"issue":"109773","key":"key20230526101648_b44-ETM-25-6-11974","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2020.109773","article-title":"IL-36 family cytokines in protective versus destructive inflammation","volume":"75","author":"Han","year":"2020","journal-title":"Cell Signal"},{"key":"key20230526101648_b45-ETM-25-6-11974","doi-asserted-by":"publisher","first-page":"24192","DOI":"10.1074\/jbc.M109.023044","article-title":"MyD88 adapter-like (Mal)\/TIRAP interaction with TRAF6 is critical for TLR2- and TLR4-mediated NF-kappaB proinflammatory responses","volume":"284","author":"Verstak","year":"2009","journal-title":"J Biol Chem"},{"issue":"80","key":"key20230526101648_b46-ETM-25-6-11974","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00080","article-title":"RNA-Seq analysis of IL-1B and IL-36 responses in epidermal keratinocytes identifies a shared MyD88-dependent gene signature","volume":"9","author":"Swindell","year":"2018","journal-title":"Front Immunol"},{"key":"key20230526101648_b47-ETM-25-6-11974","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1097\/MIB.0000000000000654","article-title":"Increased expression of interleukin-36, a member of the interleukin-1 cytokine family, in inflammatory bowel disease","volume":"22","author":"Nishida","year":"2016","journal-title":"Inflamm Bowel Dis"},{"issue":"5140691","key":"key20230526101648_b48-ETM-25-6-11974","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/5140691","article-title":"Differential expression of IL-36 family members and IL-38 by immune and nonimmune cells in patients with active inflammatory bowel disease","volume":"2018","author":"Fonseca-Camarillo","year":"2018","journal-title":"Biomed Res Int"},{"key":"key20230526101648_b49-ETM-25-6-11974","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1136\/gutjnl-2015-310374","article-title":"IL-36R signalling activates intestinal epithelial cells and fibroblasts and promotes mucosal healing in vivo","volume":"66","author":"Scheibe","year":"2017","journal-title":"Gut"},{"key":"key20230526101648_b50-ETM-25-6-11974","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1038\/mi.2015.134","article-title":"IL-36\u03b1 expression is elevated in ulcerative colitis and promotes colonic inflammation","volume":"9","author":"Russell","year":"2016","journal-title":"Mucosal Immunol"},{"key":"key20230526101648_b51-ETM-25-6-11974","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1038\/mi.2017.21","article-title":"IL-36\u03b3 signaling controls the induced regulatory T cell-Th9 cell balance via NF\u03baB activation and STAT transcription factors","volume":"10","author":"Harusato","year":"2017","journal-title":"Mucosal Immunol"},{"issue":"69","key":"key20230526101648_b52-ETM-25-6-11974","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2015.00069","article-title":"Interleukin(IL)-36\u03b1 and IL-36\u03b3 induce proinflammatory mediators from human colonic subepithelial myofibroblasts","volume":"2","author":"Kanda","year":"2015","journal-title":"Front Med (Lausanne)"},{"issue":"108762","key":"key20230526101648_b53-ETM-25-6-11974","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.108762","article-title":"Interleukin-36\u03b2 exacerbates DSS-induce acute colitis via inhibiting Foxp3+ regulatory T cell response and increasing Th2 cell response","volume":"108","author":"Zhu","year":"2022","journal-title":"Int Immunopharmacol"},{"issue":"154963","key":"key20230526101648_b54-ETM-25-6-11974","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2019.154963","article-title":"Interleukin-38 is elevated in inflammatory bowel diseases and suppresses intestinal inflammation","volume":"127","author":"Xie","year":"2020","journal-title":"Cytokine"},{"key":"key20230526101648_b55-ETM-25-6-11974","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/ni.2025","article-title":"Border patrol: Regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22","volume":"12","author":"Sonnenberg","year":"2011","journal-title":"Nat Immunol"},{"key":"key20230526101648_b56-ETM-25-6-11974","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1084\/jem.20140678","article-title":"CX3CR1+ mononuclear phagocytes support colitis-associated innate lymphoid cell production of IL-22","volume":"211","author":"Longman","year":"2014","journal-title":"J Exp Med"},{"key":"key20230526101648_b57-ETM-25-6-11974","doi-asserted-by":"publisher","first-page":"34","DOI":"10.4049\/jimmunol.1501312","article-title":"Cutting edge: IL-36 receptor promotes resolution of intestinal damage","volume":"196","author":"Medina-Contreras","year":"2016","journal-title":"J Immunol"},{"key":"key20230526101648_b58-ETM-25-6-11974","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1016\/j.ajpath.2016.02.001","article-title":"Neutrophil-Epithelial Interactions: A Double-Edged Sword","volume":"186","author":"Parkos","year":"2016","journal-title":"Am J Pathol"},{"key":"key20230526101648_b59-ETM-25-6-11974","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1053\/j.gastro.2016.07.008","article-title":"Inflammation and the intestinal barrier: Leukocyte-epithelial cell interactions, cell junction remodeling, and mucosal repair","volume":"151","author":"Luissint","year":"2016","journal-title":"Gastroenterology"},{"key":"key20230526101648_b60-ETM-25-6-11974","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/nri3608","article-title":"Intestinal epithelial cells: Regulators of barrier function and immune homeostasis","volume":"14","author":"Peterson","year":"2014","journal-title":"Nat Rev Immunol"},{"issue":"6458","key":"key20230526101648_b61-ETM-25-6-11974","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21186458","article-title":"Interleukin-36 cytokine\/receptor signaling: A new target for tissue fibrosis","volume":"21","author":"Melton","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"162","key":"key20230526101648_b62-ETM-25-6-11974","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.00162","article-title":"The molecular mechanism of transforming growth factor-\u03b2 signaling for intestinal fibrosis: A mini-review","volume":"10","author":"Yun","year":"2019","journal-title":"Front Pharmacol"},{"key":"key20230526101648_b63-ETM-25-6-11974","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/s41575-021-00543-0","article-title":"Revisiting fibrosis in inflammatory bowel disease: The gut thickens","volume":"19","author":"D'Alessio","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"e144336","key":"key20230526101648_b64-ETM-25-6-11974","doi-asserted-by":"publisher","DOI":"10.1172\/JCI144336","article-title":"IL-36 in chronic inflammation and fibrosis-bridging the gap?","volume":"131","author":"Elias","year":"2021","journal-title":"J Clin Invest"},{"key":"key20230526101648_b65-ETM-25-6-11974","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1681\/ASN.2016080840","article-title":"IL-36 signaling facilitates activation of the NLRP3 inflammasome and IL-23\/IL-17 axis in renal inflammation and fibrosis","volume":"28","author":"Chi","year":"2017","journal-title":"J Am Soc Nephrol"},{"issue":"eaax4783","key":"key20230526101648_b66-ETM-25-6-11974","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aax4783","article-title":"Interleukin-36\u03b3-producing macrophages drive IL-17-mediated fibrosis","volume":"4","author":"Sommerfeld","year":"2019","journal-title":"Sci Immunol"},{"key":"key20230526101648_b67-ETM-25-6-11974","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1097\/MPA.0000000000000765","article-title":"Interleukin-36\u03b1 induces inflammatory mediators from human pancreatic myofibroblasts via a MyD88 dependent pathway","volume":"46","author":"Nishida","year":"2017","journal-title":"Pancreas"},{"issue":"429","key":"key20230526101648_b68-ETM-25-6-11974","doi-asserted-by":"publisher","DOI":"10.3390\/cells11030429","article-title":"Therapeutic targeting of intestinal fibrosis in Crohn's disease","volume":"11","author":"Santacroce","year":"2022","journal-title":"Cells"},{"key":"key20230526101648_b69-ETM-25-6-11974","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/imr.12974","article-title":"Novel mechanisms and clinical trial endpoints in intestinal fibrosis","volume":"302","author":"Wang","year":"2021","journal-title":"Immunol Rev"},{"issue":"e138423","key":"key20230526101648_b70-ETM-25-6-11974","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0138423","article-title":"Interleukin (IL)-1\u03b2 is a strong inducer of IL-36\u03b3 expression in human colonic myofibroblasts","volume":"10","author":"Takahashi","year":"2015","journal-title":"PLoS One"},{"key":"key20230526101648_b71-ETM-25-6-11974","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"key20230526101648_b72-ETM-25-6-11974","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1053\/j.gastro.2021.10.035","article-title":"Colorectal cancer in inflammatory bowel disease: Mechanisms and management","volume":"162","author":"Shah","year":"2022","journal-title":"Gastroenterology"},{"issue":"3062","key":"key20230526101648_b73-ETM-25-6-11974","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21093062","article-title":"Immunological mechanisms in inflammation-associated colon carcinogenesis","volume":"21","author":"Hirano","year":"2020","journal-title":"Int J Mol Sci"},{"key":"key20230526101648_b74-ETM-25-6-11974","first-page":"8077","article-title":"Decreased expression of interleukin-36\u03b1 predicts poor prognosis in colorectal cancer patients","volume":"7","author":"Wang","year":"2014","journal-title":"Int J Clin Exp Patho"},{"issue":"1803","key":"key20230526101648_b75-ETM-25-6-11974","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01803","article-title":"IL-36\u03b2 promotes CD8+ T cell activation and antitumor immune responses by activating mTORC1","volume":"10","author":"Zhao","year":"2019","journal-title":"Front Immunol"},{"key":"key20230526101648_b76-ETM-25-6-11974","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1007\/s00262-013-1471-1","article-title":"Decreased expression of interleukin-36\u03b1 correlates with poor prognosis in hepatocellular carcinoma","volume":"62","author":"Pan","year":"2013","journal-title":"Cancer Immunology, Immunotherapy"},{"issue":"108152","key":"key20230526101648_b77-ETM-25-6-11974","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.108152","article-title":"Interleukin-36\u03b1 inhibits colorectal cancer metastasis by enhancing the infiltration and activity of CD8+ T lymphocytes","volume":"100","author":"Wei","year":"2021","journal-title":"Int Immunopharmacol"},{"key":"key20230526101648_b78-ETM-25-6-11974","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.ccell.2015.07.014","article-title":"IL-36\u03b3 transforms the tumor microenvironment and promotes type 1 lymphocyte-mediated antitumor immune responses","volume":"28","author":"Wang","year":"2015","journal-title":"Cancer Cell"},{"issue":"1990","key":"key20230526101648_b79-ETM-25-6-11974","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01990","article-title":"Positive & negative roles of innate effector cells in controlling cancer progression","volume":"9","author":"Stolk","year":"2018","journal-title":"Front Immunol"},{"issue":"1906","key":"key20230526101648_b80-ETM-25-6-11974","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01906","article-title":"CD8+ T lymphocyte and NK cell network: Circuitry in the cytotoxic domain of immunity","volume":"10","author":"Uzhachenko","year":"2019","journal-title":"Front Immunol"},{"issue":"e1322238","key":"key20230526101648_b81-ETM-25-6-11974","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2017.1322238","article-title":"Tbet and IL-36\u03b3 cooperate in therapeutic DC-mediated promotion of ectopic lymphoid organogenesis in the tumor microenvironment","volume":"6","author":"Weinstein","year":"2017","journal-title":"Oncoimmunology"},{"key":"key20230526101648_b82-ETM-25-6-11974","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.canlet.2019.11.009","article-title":"Immune cells within the tumor microenvironment: Biological functions and roles in cancer immunotherapy","volume":"470","author":"Lei","year":"2020","journal-title":"Cancer Lett"},{"issue":"eabf9419","key":"key20230526101648_b83-ETM-25-6-11974","doi-asserted-by":"publisher","DOI":"10.1126\/science.abf9419","article-title":"Tertiary lymphoid structures in cancer","volume":"375","author":"Schumacher","year":"2022","journal-title":"Science"},{"key":"key20230526101648_b84-ETM-25-6-11974","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s00262-018-2259-0","article-title":"Association of IL-36\u03b3 with tertiary lymphoid structures and inflammatory immune infiltrates in human colorectal cancer","volume":"68","author":"Weinstein","year":"2019","journal-title":"Cancer Immunol Immunother"},{"key":"key20230526101648_b85-ETM-25-6-11974","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1007\/s00262-021-02860-4","article-title":"IL-36\u03b3-armed oncolytic virus exerts superior efficacy through induction of potent adaptive antitumor immunity","volume":"70","author":"Yang","year":"2021","journal-title":"Cancer Immunol Immunother"},{"key":"key20230526101648_b86-ETM-25-6-11974","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/bs.acr.2015.04.003","article-title":"Therapeutic lymphoid organogenesis in the tumor microenvironment","volume":"128","author":"Weinstein","year":"2015","journal-title":"Adv Cancer Res"},{"issue":"e2103035","key":"key20230526101648_b87-ETM-25-6-11974","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202103035","article-title":"IL-36\u03b3 and IL-36Ra reciprocally regulate colon inflammation and tumorigenesis by modulating the cell-matrix adhesion network and Wnt signaling","volume":"9","author":"Yang","year":"2022","journal-title":"Adv Sci (Weinh)"},{"key":"key20230526101648_b88-ETM-25-6-11974","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1038\/s41388-022-02281-2","article-title":"IL-36 signalling enhances a pro-tumorigenic phenotype in colon cancer cells with cancer cell growth restricted by administration of the IL-36R antagonist","volume":"41","author":"Baker","year":"2022","journal-title":"Oncogene"},{"key":"key20230526101648_b89-ETM-25-6-11974","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.semcancer.2022.03.020","article-title":"The evolutionary legacy of immune checkpoint inhibitors","volume":"86","author":"Kaushik","year":"2022","journal-title":"Semin Cancer Biol"},{"key":"key20230526101648_b90-ETM-25-6-11974","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1158\/2159-8290.CD-18-0367","article-title":"Fundamental mechanisms of immune checkpoint blockade therapy","volume":"8","author":"Wei","year":"2018","journal-title":"Cancer Discov"},{"issue":"1922","key":"key20230526101648_b91-ETM-25-6-11974","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13081922","article-title":"Anti-PD-1\/PD-L1 based combination immunotherapy to boost antigen-specific CD8+ T cell response in hepatocellular carcinoma","volume":"13","author":"Pe\u00f1a-Asensio","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"eaat9143","key":"key20230526101648_b92-ETM-25-6-11974","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aat9143","article-title":"Durable anticancer immunity from intratumoral administration of IL-23, IL-36\u03b3, and OX40L mRNAs","volume":"11","author":"Hewitt","year":"2019","journal-title":"Sci Transl Med"},{"key":"key20230526101648_b93-ETM-25-6-11974","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1056\/NEJMoa2111563","article-title":"Trial of spesolimab for generalized pustular psoriasis","volume":"385","author":"Bachelez","year":"2021","journal-title":"New Engl J Med"},{"key":"key20230526101648_b94-ETM-25-6-11974","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1080\/14740338.2022.2103536","article-title":"Safety and tolerability of spesolimab in patients with ulcerative colitis","volume":"22","author":"Ferrante","year":"2023","journal-title":"Expert Opin Drug Saf"}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"deposited":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T10:19:25Z","timestamp":1685096365000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/etm.2023.11974"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,21]]},"references-count":94,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,4,21]]}},"URL":"https:\/\/doi.org\/10.3892\/etm.2023.11974","relation":{},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"value":"1792-0981","type":"print"},{"value":"1792-1015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,21]]},"article-number":"275"}}